Skip to main content

Grafa News and Videos — Page 1106

Grafa Headlines

Latest

Grafa

AN2 Therapeutics reports positive efficacy data for Chagas disease candidate

AN2 Therapeutics (NASDAQ:ANTX) announced positive data today from two separate studies evaluating its investigational oral CPSF3 inhibitor, AN2-502998, for the treatment of chronic Chagas disease—a parasitic condition caused by Trypanosoma cruzi that affects millions globally.

Read more: AN2 Therapeutics reports positive efficacy data for Chagas disease candidate
Grafa

Hong Kong’s Click Holdings reveals 73% revenue surge as senior care demand rises

Click Holdings (NASDAQ:CLIK), a Hong Kong-based provider of human resources and senior care solutions, reported strong operational growth for the third quarter of its 2025/26 financial year, covering the period from January to March 2026.

Read more: Hong Kong’s Click Holdings reveals 73% revenue surge as senior care demand rises
Grafa
Retail

Caleres reports Q1 2026 growth driven by strong brand portfolio performance

Caleres (NYSE:CAL), a portfolio of consumer-driven footwear brands, reported financial results for the first quarter of 2026 today, highlighted by a significant performance gap between its wholesale brand operations and its retail footprint.

Read more: Caleres reports Q1 2026 growth driven by strong brand portfolio performance

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift